Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants
Trial Parameters
Brief Summary
The DS Prime Taper EV dental implant system was recently launched on the implant market by Dentsply Sirona (York, PA, USA). Dental implant systems are undergoing rapid evolution, ultimately driven by their broad therapeutic indications. As manufacturers strive to keep up with the demands of a growing market, designs are changing faster than clinical evaluation. This means that the time needed to assess medium- and long-term clinical outcomes before designs change again cannot be met. Clinicians need to have a "real" analysis of the clinical performance of implants before using them. Therefore, reporting of results is necessary to avoid use in patients without proper practical checks even before the recommended 10- and 15-year follow-up periods.
Eligibility Criteria
Inclusion Criteria: * All the patients whom received at least one DS Prime Taper implant. Exclusion Criteria: * When dental implant surgery is contraindicated.